Heart disease, clinical proteomics and mass spectrometry
about
Proteomic changes in hearts of kyphoscoliosis (ky) mutant mice in the absence of structural pathology: implication for the analysis of early human heart disease.Human body fluid proteome analysis.Using SELDI-TOF MS to identify serum biomarkers of rheumatoid arthritis.Cardiovascular proteomics: implications for clinical applicationsInvestigation of an albumin-enriched fraction of human serum and its albuminome.Proteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats.Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.Protein analysis by shotgun/bottom-up proteomicsA fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid.Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1.Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue.A proteomic primer for the clinicianAssessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples.Recent advances in cardiovascular proteomics.Expanding proteomics into the analysis of chiral drugs.Myofilament proteins: From cardiac disorders to proteomic changes.Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses.Proteomic and network analysis of human serum albuminome by integrated use of quick crosslinking and two-step precipitation.Characterization of peptides and proteins in commercial HSA solutions.Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics andin vitro diagnostics to generate reliable results
P2860
Q33240258-FE3E8D5A-36D8-4951-A751-D88EF1368D32Q33262623-0AD60AB9-96E3-4876-8399-3F0FFDC77A9EQ33328566-FE12D004-863E-417D-BE05-A7E3809F6BC9Q33579184-63EF3FA6-420A-4CAF-8CBD-6F3929941FE4Q33701508-03B83743-3970-4FDE-98A2-DA3506FE1FCEQ34112124-298A8C29-342E-441D-BCD4-D6F135C01163Q34250328-B7AECD1C-5745-4948-844F-1F1BF4E63582Q34600986-E627568B-CA54-4E8B-A1ED-ED7D117D6304Q35156254-4ECFD5A0-9CC3-4334-8E4F-800C18D7A142Q35574360-DF1D8A99-E314-422E-BA29-DFDDDB8DE3ECQ36175267-AAE445A5-6A52-42CD-8C4C-F2C4C6CBFE1EQ36698789-E5E59509-BB1A-426C-966E-A90AAE3C8C4AQ36931787-7B3B5041-9988-467F-A4AD-665EAB5D980BQ37000977-38FEA7C6-3C00-41BC-8E48-F3758CDC9CC6Q37492369-441286B9-DEB1-4CB5-AB39-8BDDDCF7DCDFQ37817240-F03CD629-50DC-4B27-ADA0-B2DAB642FF44Q38295801-34555F58-604C-45F4-BDF7-CA81E1E94431Q41550303-FF931DF2-0A9A-4C0F-87E7-CCCCF84E8355Q43250685-E8376D80-0BA9-47DD-832B-76E36F86257BQ57995087-79384412-EA04-4AEC-B690-73119B36A788
P2860
Heart disease, clinical proteomics and mass spectrometry
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Heart disease, clinical proteomics and mass spectrometry
@ast
Heart disease, clinical proteomics and mass spectrometry
@en
type
label
Heart disease, clinical proteomics and mass spectrometry
@ast
Heart disease, clinical proteomics and mass spectrometry
@en
prefLabel
Heart disease, clinical proteomics and mass spectrometry
@ast
Heart disease, clinical proteomics and mass spectrometry
@en
P2093
P356
P1433
P1476
Heart disease, clinical proteomics and mass spectrometry
@en
P2093
Brian A Stanley
Jennifer E Van Eyk
Rebekah L Gundry
Robert J Cotter
P304
P356
10.1155/2004/965261
P577
2004-01-01T00:00:00Z